Tokyo Tape
Sign in
← Nissan Chemical Corporatiom

Quarterly report · Q3

4021.TEDINET S100SRRZ
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥155.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥228.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥159.2bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥33.4bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥38.8bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥35.0bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥55.8bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥41.3bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥35.7bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥41.3bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥26.0bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥41.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥30.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥26.1bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥31.0bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥309.7bnat 2023-12-31Cons.Assets
Total assets¥298.7bnat 2023-03-31Cons.Assets
Total assets¥276.6bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥88.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥77.2bnat 2023-03-31Cons.Liabilities
Net assets / equity¥221.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥221.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥216.2bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥25.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥29.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥25.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥29.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥25.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥34.7bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥33.7bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥35.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥37.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥11.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥19.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥25.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥25.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥37.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥186.022023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.442023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥291.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥217.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.212022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio70.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-12-31¥18.3bn
Otherother segmentsrevenue external2023-04-01 → 2023-12-31¥7.3bn
Otherother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥11.0bn
Otherother segmentssegment profit2023-04-01 → 2023-12-31−¥43m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥82.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31−¥20.5bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥62.3bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥3.8bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥48.5bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥38.1bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥10.3bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥14.5bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥27.5bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥18.3bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9.3bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥283m
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue2023-04-01 → 2023-12-31¥61.9bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-12-31¥49.6bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥12.3bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-12-31¥17.4bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue2023-04-01 → 2023-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥57m
jpcrp040300-q3r_E00759-000Medicinesreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue2023-04-01 → 2023-12-31¥77.1bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue external2023-04-01 → 2023-12-31¥57.7bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥19.4bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentsegment profit2023-04-01 → 2023-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥238.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥175.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥62.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥37.3bn
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥19.1bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥8.2bn
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥11.0bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥343m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥80.6bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31−¥22.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥58.3bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥4.1bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥48.8bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.4bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥8.4bn
jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥15.2bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥29.9bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.5bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9.4bn
jpcrp040300-q3r_E00759-000Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥62.6bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥50.6bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥12.0bn
jpcrp040300-q3r_E00759-000Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥20.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue2022-04-01 → 2022-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.8bn
jpcrp040300-q3r_E00759-000Medicinesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥10m
jpcrp040300-q3r_E00759-000Medicinesreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.1bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue2022-04-01 → 2022-12-31¥74.7bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue external2022-04-01 → 2022-12-31¥57.1bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥17.6bn
jpcrp040300-q3r_E00759-000Wholesalereportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥239.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥181.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥58.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥42.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 516
ItemContextValueUnit
Income taxes payableCurrentQuarterInstant1065000000JPY
Provision for bonusesPrior1YearInstant2413000000JPY
Provision for bonusesCurrentQuarterInstant790000000JPY
Provision for business structure improvement clPrior1YearInstant418000000JPY
Provision for business structure improvement clCurrentQuarterInstant379000000JPY
Other clPrior1YearInstant15556000000JPY
Other clCurrentQuarterInstant21125000000JPY
Current liabilitiesPrior1YearInstant72161000000JPY
Current liabilitiesCurrentQuarterInstant82400000000JPY
Long term loans payablePrior1YearInstant1338000000JPY
Long term loans payableCurrentQuarterInstant1079000000JPY
Deferred tax liabilitiesPrior1YearInstant98000000JPY
Deferred tax liabilitiesCurrentQuarterInstant1368000000JPY
Provision for loss on business of subsidiaries and affiliates nclPrior1YearInstant626000000JPY
Provision for loss on business of subsidiaries and affiliates nclCurrentQuarterInstant453000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant256000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant245000000JPY
Net defined benefit liabilityPrior1YearInstant377000000JPY
Net defined benefit liabilityCurrentQuarterInstant432000000JPY
Other nclPrior1YearInstant2331000000JPY
Other nclCurrentQuarterInstant2371000000JPY
Noncurrent liabilitiesPrior1YearInstant5027000000JPY
Noncurrent liabilitiesCurrentQuarterInstant5951000000JPY
LiabilitiesPrior1YearInstant77188000000JPY
LiabilitiesCurrentQuarterInstant88351000000JPY
Capital stockPrior1YearInstant18942000000JPY
Capital stockCurrentQuarterInstant18942000000JPY
Capital surplusPrior1YearInstant13613000000JPY
Capital surplusCurrentQuarterInstant13613000000JPY
Retained earningsPrior1YearInstant182400000000JPY
Retained earningsCurrentQuarterInstant176149000000JPY
Treasury stockPrior1YearInstant-6111000000JPY
Treasury stockCurrentQuarterInstant-2638000000JPY
Shareholders equityPrior1YearInstant208844000000JPY
Shareholders equityCurrentQuarterInstant206066000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant7678000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant8561000000JPY
Foreign currency translation adjustmentPrior1YearInstant1735000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant3258000000JPY
Remeasurements of defined benefit plansPrior1YearInstant159000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant143000000JPY
Valuation and translation adjustmentsPrior1YearInstant9574000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant11963000000JPY
Non controlling interestsPrior1YearInstant3107000000JPY
Non controlling interestsCurrentQuarterInstant3325000000JPY
Net assetsPrior1YearInstant221526000000JPY
Net assetsCurrentQuarterInstant221355000000JPY
Liabilities and net assetsPrior1YearInstant298715000000JPY
Liabilities and net assetsCurrentQuarterInstant309707000000JPY
Net salesPrior1YTDDuration159234000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass